Jason S. Troutt

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9

Holly E. Careskey, Roslyn Davis, William E. Alborn et al. · Journal of Lipid Research · 2007 · 310 citations · Full text

High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol

Greg Welder, Issam Zineh, Michael Pacanowski et al. · Journal of Lipid Research · 2010 · 244 citations · Full text

Immunology, High-dose Atorvastatin, Hyperlipidemia +17

Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors

Karin Leander, Anders Mälarstig, Ferdinand M. van’t Hooft et al. · Circulation · 2016 · 222 citations · Full text

Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans

Lena Persson, Guoqing Cao, Lars Ståhle et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 169 citations · Full text

Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population

Qin Cui, Xianxia Ju, Tao Yang et al. · Atherosclerosis · 2010 · 141 citations

Metabolic Syndrome, Body Composition, Multiple Metabolic Factors +11